- Home
- ATUS vs CVAC Comparison
ATUS vs CVAC Comparison
Compare ATUS & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATUS
- CVAC
- Stock Information
- Founded
- ATUS 2015
- CVAC 2000
- Country
- ATUS United States
- CVAC Germany
- Employees
- ATUS N/A
- CVAC N/A
- Industry
- ATUS Cable & Other Pay Television Services
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- ATUS Telecommunications
- CVAC Health Care
- Exchange
- ATUS Nasdaq
- CVAC Nasdaq
- Market Cap
- ATUS 1.0B
- CVAC 1.2B
- IPO Year
- ATUS 2017
- CVAC 2020
- Fundamental
- Price
- ATUS $2.11
- CVAC $5.38
- Analyst Decision
- ATUS Hold
- CVAC Hold
- Analyst Count
- ATUS 6
- CVAC 3
- Target Price
- ATUS $2.88
- CVAC $6.83
- AVG Volume (30 Days)
- ATUS 3.3M
- CVAC 422.9K
- Earning Date
- ATUS 11-06-2025
- CVAC 11-12-2025
- Dividend Yield
- ATUS N/A
- CVAC N/A
- EPS Growth
- ATUS N/A
- CVAC N/A
- EPS
- ATUS N/A
- CVAC 1.01
- Revenue
- ATUS $8,762,212,000.00
- CVAC $599,540,810.00
- Revenue This Year
- ATUS N/A
- CVAC N/A
- Revenue Next Year
- ATUS N/A
- CVAC $23.40
- P/E Ratio
- ATUS N/A
- CVAC $5.35
- Revenue Growth
- ATUS N/A
- CVAC 675.15
- 52 Week Low
- ATUS $1.95
- CVAC $2.37
- 52 Week High
- ATUS $3.20
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- ATUS 35.51
- CVAC 49.44
- Support Level
- ATUS $2.12
- CVAC $5.35
- Resistance Level
- ATUS $2.28
- CVAC $5.41
- Average True Range (ATR)
- ATUS 0.13
- CVAC 0.04
- MACD
- ATUS -0.04
- CVAC -0.00
- Stochastic Oscillator
- ATUS 1.94
- CVAC 50.00
About ATUS Altice USA Inc.
Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and businesses in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.